Evidence map›Paper›PMID 39235202›Full record

ArticleJournal of clinical laboratory analysis2024

Implicit Flow Cytometric Diagnosis of Classic Hodgkin Lymphoma Using CD3

Curtis Gravenmier, Jinming Song, Haipeng Shao

Abstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Curtis GravenmierDepartment of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
Jinming SongDepartment of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
Haipeng ShaoDepartment of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.ORCID https://orcid.org/0000-0002-7207-731X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFlow cytometry is not routinely performed in clinical laboratories for the diagnosis of classic Hodgkin lymphoma (CHL).

methodsFourteen cases of CHL and 132 cases of the control group were studied by 10-color flow cytometry, with markers including CD3, CD4, CD7, CD8, and CD26, as well as calculated parameters such as the CD4:CD8 ratio, percent CD3

resultsCHL cases showed a median percent CD3

conclusionIn this study, we used flow cytometry to demonstrate increased CD3

Indexed as

Flow CytometryHodgkin DiseaseAdolescentAdultAgedCase-Control StudiesCD3 ComplexCD4 AntigensCD4-Positive T-LymphocytesDipeptidyl Peptidase 4FemaleHumansMaleMiddle AgedROC CurveT-LymphocytesCD3 ComplexCD4 AntigensDipeptidyl Peptidase 4CD26CD4classic Hodgkin lymphomaflow cytometryT‐cells

Identifiers

PMID39235202
PMCPMC11484709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.